Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Géher P[au]:

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. van der Heijde D et al. Ann Rheum Dis. (2017)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Braun J et al. Ann Rheum Dis. (2011)

[Professor Béla Gömör has turned 80]. Géher P et al. Orv Hetil. (2018)

Search results

Items: 1 to 50 of 58

1.

A prospective observational study on the long-term results of 90Yttrium citrate radiosynoviorthesis of synovitis in osteoarthritis of the knee joint.

Szentesi M, Nagy Z, Géher P, Papp I, Kampen WU.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1633-1641. doi: 10.1007/s00259-019-04350-3. Epub 2019 May 25.

PMID:
31129693
2.

[Professor Béla Gömör has turned 80].

Géher P.

Orv Hetil. 2018 Jan;159(4):123. doi: 10.1556/650.2018.HO2591. Hungarian. No abstract available.

PMID:
29353501
3.

[Peroral and transdermal application of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of regional musculoskeletal pain syndromes].

Hodinka L, Bálint G, Budai E, Géher P, Papp R, Somogyi P, Szántó S, Vereckei E.

Orv Hetil. 2017 Dec;158(Suppl 3):3-30. doi: 10.1556/650.2017.30902. Review. Hungarian.

PMID:
29307215
4.

Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study.

Khan NA, Spencer HJ, Nikiphorou E, Naranjo A, Alten R, Chirieac RM, Drosos AA, Géher P, Inanc N, Kerzberg E, Ancuta CM, Müller R, Ørnbjerg L, Sokka T.

Rheumatology (Oxford). 2017 Aug 1;56(8):1395-1400. doi: 10.1093/rheumatology/kex076.

PMID:
28575509
5.

[Initial experiences with VATS lobectomy].

Gehér P, Füredi Á, Kecskés LI, Kiss B.

Magy Seb. 2017 Mar;70(1):43-47. doi: 10.1556/1046.70.2017.1.6. Hungarian.

PMID:
28294667
6.

Adaptation of the osteoarthritis-specific quality of life scale (the OAQoL) for use in Germany, Hungary, Italy, Spain and Turkey.

Wilburn J, McKenna SP, Kutlay Ş, Bender T, Braun J, Castillo-Gallego C, Favero M, Geher P, Kiltz U, Martin-Mola E, Ramonda R, Rouse M, Tennant A, Küçükdeveci AA.

Rheumatol Int. 2017 May;37(5):727-734. doi: 10.1007/s00296-017-3664-y. Epub 2017 Feb 15.

PMID:
28197718
7.

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J.

Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. Review.

PMID:
28087505
8.

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages.

Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J.

RMD Open. 2016 Oct 4;2(2):e000311. eCollection 2016.

9.

Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe.

Szántó S, Poór G, Opris D, Iaremenko O, Procházková L, Kuuse R, Nagy O, Chernyshov V, Géher P.

J Comp Eff Res. 2016 Aug;5(5):475-85. doi: 10.2217/cer-2016-0020. Epub 2016 Jul 15.

PMID:
27417564
10.

Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective.

Péntek M, Rojkovich B, Czirják L, Géher P, Keszthelyi P, Kovács A, Kovács L, Szabó Z, Szekanecz Z, Tamási L, Tóth ÁE, Ujfalussy I, Hevér NV, Strbák B, Baji P, Brodszky V, Gulácsi L.

Eur J Health Econ. 2014 May;15 Suppl 1:S73-82. doi: 10.1007/s10198-014-0596-2. Epub 2014 May 16.

PMID:
24832838
11.

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis.

Baji P, Péntek M, Szántó S, Géher P, Gulácsi L, Balogh O, Brodszky V.

Eur J Health Econ. 2014 May;15 Suppl 1:S45-52. doi: 10.1007/s10198-014-0593-5. Epub 2014 May 16. Review.

12.

[Long-term survival after lung-sparing central bronchoplastic procedures [CBPs] for malignant tumors].

Kecskés LI, Bátor G, Füredi A, Gehér P, Kiss B, Stankovics P.

Magy Seb. 2013 Dec;66(6):338-47. doi: 10.1556/MaSeb.66.2013.6.6. Hungarian.

PMID:
24333979
13.

[Physiotherapy from the view of health insurance financing].

Géher P.

Orv Hetil. 2013 Dec 1;154(48):1917-23. doi: 10.1556/OH.2013.29762. Review. Hungarian.

PMID:
24273291
14.

Evidence-based hydro- and balneotherapy in Hungary--a systematic review and meta-analysis.

Bender T, Bálint G, Prohászka Z, Géher P, Tefner IK.

Int J Biometeorol. 2014 Apr;58(3):311-23. doi: 10.1007/s00484-013-0667-6. Epub 2013 May 16. Review.

15.

The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis.

Pásztói M, Sódar B, Misják P, Pálóczi K, Kittel Á, Tóth K, Wellinger K, Géher P, Nagy G, Lakatos T, Falus A, Buzás EI.

Immunol Lett. 2013 Jan;149(1-2):71-6. doi: 10.1016/j.imlet.2012.10.012. Epub 2012 Oct 23.

PMID:
23099419
16.

Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.

Sieper J, Srinivasan S, Zamani O, Mielants H, Choquette D, Pavelka K, Loft AG, Géher P, Danda D, Reitblat T, Cantini F, Ancuta C, Erdes S, Raffayová H, Keat A, Gaston JS, Praprotnik S, Vastesaeger N.

Ann Rheum Dis. 2013 Oct;72(10):1621-7. doi: 10.1136/annrheumdis-2012-201777. Epub 2012 Oct 13.

PMID:
23065731
17.

Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study.

Dougados M, Braun J, Szanto S, Combe B, Geher P, Leblanc V, Logeart I.

Rheumatology (Oxford). 2012 Sep;51(9):1687-96. doi: 10.1093/rheumatology/kes125. Epub 2012 May 30.

PMID:
22653382
18.

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Khan NA, Spencer HJ, Abda EA, Alten R, Pohl C, Ancuta C, Cazzato M, Géher P, Gossec L, Henrohn D, Hetland ML, Inanc N, Jacobs JW, Kerzberg E, Majdan M, Oyoo O, Peredo-Wende RA, Selim ZI, Skopouli FN, Sulli A, Hørslev-Petersen K, Taylor PC, Sokka T; QUEST-RA group.

Ann Rheum Dis. 2012 Dec;71(12):1942-9. doi: 10.1136/annrheumdis-2011-201142. Epub 2012 Apr 24.

19.

Citrullination under physiological and pathological conditions.

Baka Z, György B, Géher P, Buzás EI, Falus A, Nagy G.

Joint Bone Spine. 2012 Oct;79(5):431-6. doi: 10.1016/j.jbspin.2012.01.008. Epub 2012 Feb 25. Review.

PMID:
22366145
20.
21.

Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.

Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G.

Int Immunol. 2011 Jun;23(6):405-14. doi: 10.1093/intimm/dxr026. Epub 2011 May 19.

PMID:
21602177
22.

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D.

Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.

23.

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).

Dougados M, Braun J, Szanto S, Combe B, Elbaz M, Geher P, Thabut G, Leblanc V, Logeart I.

Ann Rheum Dis. 2011 May;70(5):799-804. doi: 10.1136/ard.2010.139261. Epub 2011 Feb 13. Erratum in: Ann Rheum Dis. 2011 Jul;70(7):1349.

24.

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.

Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D, Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA, Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G, Henrohn D, Horslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J, Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D, Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN, Stropuviene S, Toloza S, Valter I, Woolf A, Yamanaka H; QUEST-RA.

Arthritis Res Ther. 2010;12(2):R42. doi: 10.1186/ar2951. Epub 2010 Mar 12.

25.

Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee.

Pavelka K, Coste P, Géher P, Krejci G.

Clin Rheumatol. 2010 Jun;29(6):659-70. doi: 10.1007/s10067-010-1384-8. Epub 2010 Feb 24. Erratum in: Clin Rheumatol. 2010 Jul;29(7):819-20.

PMID:
20179981
26.

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.

Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, Horváth G, Koó E, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Scand J Rheumatol. 2010 Aug;39(4):303-9. doi: 10.3109/03009740903468982.

PMID:
20166848
27.

Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.

Pásztói M, Nagy G, Géher P, Lakatos T, Tóth K, Wellinger K, Pócza P, György B, Holub MC, Kittel A, Pálóczy K, Mazán M, Nyirkos P, Falus A, Buzas EI.

Arthritis Res Ther. 2009;11(3):R68. doi: 10.1186/ar2697. Epub 2009 May 14.

28.

Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.

Brodszky V, Bálint P, Géher P, Hodinka L, Horváth G, Koó É, Péntek M, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Rheumatol Int. 2009 Dec;30(2):199-205. doi: 10.1007/s00296-009-0936-1.

PMID:
19381635
29.

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; QUEST-RA Group.

Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14.

30.

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis.

György B, Tóthfalusi L, Nagy G, Pásztói M, Géher P, Lörinc Z, Polgár A, Rojkovich B, Ujfalussy I, Poór G, Pócza P, Wiener Z, Misják P, Koncz A, Falus A, Buzás EI.

Arthritis Res Ther. 2008;10(5):R110. doi: 10.1186/ar2507. Epub 2008 Sep 12.

31.

[Ankylosing spondylitis in Central and Eastern Europe. Cross-sectional study on treatment modalities, disease activity and quality of life].

Ebner W, Palotai T, Codreanu C, Géher P, Pahor A, Pavelka K, Smolen J, Szechiński J, Zlnay M.

Z Rheumatol. 2008 Oct;67(6):503-10. doi: 10.1007/s00393-008-0316-3. German.

PMID:
18712402
32.

Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system.

Dudics V, Kunstár A, Kovács J, Lakatos T, Géher P, Gömör B, Monostori E, Uher F.

Cells Tissues Organs. 2009;189(5):307-16. doi: 10.1159/000140679. Epub 2008 Jun 19.

PMID:
18562787
33.

[Systemic lupus erythematosus and pregnancy].

Gáti T, Pajor A, Géher P, Nagy G.

Orv Hetil. 2008 Apr 20;149(16):723-31. doi: 10.1556/OH.2008.28295. Review. Hungarian.

PMID:
18426719
34.

[Videothoracoscopic removal of ectopic liver].

Gehér P, Füredi A, Kecskés LI.

Magy Seb. 2007 Dec;60(6):310-1. Review. Hungarian.

PMID:
18065371
35.

[Rituximab in patients with rheumatoid arthritis: systematic review].

Brodszky V, Czirják L, Géher P, Hodinka L, Kárpáti K, Péntek M, Poór G, Szekanecz Z, Gulácsi L.

Orv Hetil. 2007 Oct 7;148(40):1883-93. Review. Hungarian.

PMID:
17905683
36.

The effect of physical therapy on beta-endorphin levels.

Bender T, Nagy G, Barna I, Tefner I, Kádas E, Géher P.

Eur J Appl Physiol. 2007 Jul;100(4):371-82. Epub 2007 May 5. Review.

PMID:
17483960
37.

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.

van der Heijde D, Da Silva JC, Dougados M, Geher P, van der Horst-Bruinsma I, Juanola X, Olivieri I, Raeman F, Settas L, Sieper J, Szechinski J, Walker D, Boussuge MP, Wajdula JS, Paolozzi L, Fatenejad S; Etanercept Study 314 Investigators.

Ann Rheum Dis. 2006 Dec;65(12):1572-7. Epub 2006 Sep 12.

38.

[The role of biologic agents in the therapy of ankylosing spondylitis].

Géher P, Nagy MB, Péntek M, Tóth E, Brodszky V, Gulácsi L.

Orv Hetil. 2006 Jul 2;147(26):1203-13. Review. Hungarian.

PMID:
16898082
39.

A short Larsen score is effective when evaluating radiographs in early rheumatoid arthritis.

Palkonyai E, Larsen A, Geher P, Kolarz G, Bogye G, Temesvari P, Kaposi P, Szilagyi M, Ratko I.

Acta Radiol. 2006 Jun;47(5):484-7.

PMID:
16796311
40.

[Signal transduction abnormalities in systemic lupus erythematosus].

Nagy G, Géher P, Koncz A, Perl A.

Orv Hetil. 2005 Jul 31;146(31):1625-30. Review. Hungarian.

PMID:
16158611
41.

ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J; 'ASsessment in AS' international working group; European League Against Rheumatism.

Ann Rheum Dis. 2006 Apr;65(4):442-52. Epub 2005 Aug 26.

42.

[Mesenchymal stem cells as potential source cartilage repair].

Dudics V, Kunstár A, Géher P, Gömör B, Hangody L, Uher F.

Orv Hetil. 2005 May 29;146(22):1201-8. Review. Hungarian.

PMID:
15997666
43.

Effect of plasmapheresis on serum beta-endorphin levels.

Bender T, Polner K, Barna I, Géher P, Boke M, Haris A.

Blood Purif. 2005;23(2):141-3. Epub 2005 Jan 24.

PMID:
15668524
44.

Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion.

Ortutay Z, Polgár A, Gömör B, Géher P, Lakatos T, Glant TT, Gay RE, Gay S, Pállinger E, Farkas C, Farkas E, Tóthfalusi L, Kocsis K, Falus A, Buzás EI.

Arthritis Rheum. 2003 Aug;48(8):2163-72.

45.

[Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis].

Lovas K, Géher P, Whalley D, McKenna S, Meads D, Kaló Z.

Orv Hetil. 2002 Aug 11;143(32):1893-7. Hungarian.

PMID:
12221995
46.

Nonpharmacologic treatment of musculoskeletal disease.

Bender T, Géher P, Bálint G.

Clin J Pain. 2001 Sep;17(3):278. No abstract available.

PMID:
11587121
47.

Beta endorphin-like immunoreactivity in human aqueous humor and crystalline lens.

Bender T, Török I, Barna I, Géher P.

Peptides. 2001 Apr;22(4):685-7.

PMID:
11311740
48.

Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.

Géher P, Gömör B.

Med Sci Monit. 2001 Jan-Feb;7(1):105-7.

PMID:
11208503
49.

[Two familial cases of hereditary multiple exostoses].

Géher P, Csauth K, Kaposi NP.

Orv Hetil. 2000 Feb 6;141(6):289-93. Hungarian.

PMID:
10695353
50.

Video-assisted thoracoscopic pleurodesis for malignant pleural effusions.

Füredi A, Kecskés L, Gehér P, Kiss B.

Acta Chir Hung. 1999;38(2):155-7.

PMID:
10596319

Supplemental Content

Support Center